Literature DB >> 29847315

Dynamic PET of human liver inflammation: impact of kinetic modeling with optimization-derived dual-blood input function.

Guobao Wang1, Michael T Corwin, Kristin A Olson, Ramsey D Badawi, Souvik Sarkar.   

Abstract

The hallmark of nonalcoholic steatohepatitis is hepatocellular inflammation and injury in the setting of hepatic steatosis. Recent work has indicated that dynamic 18F-FDG PET with kinetic modeling has the potential to assess hepatic inflammation noninvasively, while static FDG-PET is less promising. Because the liver has dual blood supplies, kinetic modeling of dynamic liver PET data is challenging in human studies. This paper aims to identify the optimal dual-input kinetic modeling approach for dynamic FDG-PET of human liver inflammation. Fourteen patients with nonalcoholic fatty liver disease were included. Each patient underwent 1 h dynamic FDG-PET/CT scan and had liver biopsy within six weeks. Three models were tested for kinetic analysis: the traditional two-tissue compartmental model with an image-derived single-blood input function (SBIF), a model with population-based dual-blood input function (DBIF), and a new model with optimization-derived DBIF through a joint estimation framework. The three models were compared using Akaike information criterion (AIC), F test and histopathologic inflammation score. Results showed that the optimization-derived DBIF model improved liver time activity curve fitting and achieved lower AIC values and higher F values than the SBIF and population-based DBIF models in all patients. The optimization-derived model significantly increased FDG K1 estimates by 101% and 27% as compared with traditional SBIF and population-based DBIF. K1 by the optimization-derived model was significantly associated with histopathologic grades of liver inflammation while the other two models did not provide a statistical significance. In conclusion, modeling of DBIF is critical for dynamic liver FDG-PET kinetic analysis in human studies. The optimization-derived DBIF model is more appropriate than SBIF and population-based DBIF for dynamic FDG-PET of liver inflammation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29847315      PMCID: PMC6105275          DOI: 10.1088/1361-6560/aac8cb

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  62 in total

1.  Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply.

Authors:  G Brix; S I Ziegler; M E Bellemann; J Doll; R Schosser; R Lucht; H Krieter; D Nosske; U Haberkorn
Journal:  J Nucl Med       Date:  2001-08       Impact factor: 10.057

2.  Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs.

Authors:  Patricia Iozzo; Mikko J Jarvisalo; Jan Kiss; Ronald Borra; Gratian A Naum; Antti Viljanen; Tapio Viljanen; Amalia Gastaldelli; Emma Buzzigoli; Letizia Guiducci; Elisabetta Barsotti; Timo Savunen; Juhani Knuuti; Merja Haaparanta-Solin; Ele Ferrannini; Pirjo Nuutila
Journal:  Gastroenterology       Date:  2006-12-21       Impact factor: 22.682

3.  Noninvasive quantification of the cerebral metabolic rate for glucose using positron emission tomography, 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function.

Authors:  K Chen; D Bandy; E Reiman; S C Huang; M Lawson; D Feng; L S Yun; A Palant
Journal:  J Cereb Blood Flow Metab       Date:  1998-07       Impact factor: 6.200

Review 4.  4D image reconstruction for emission tomography.

Authors:  Andrew J Reader; Jeroen Verhaeghe
Journal:  Phys Med Biol       Date:  2014-10-31       Impact factor: 3.609

5.  An optimization transfer algorithm for nonlinear parametric image reconstruction from dynamic PET data.

Authors:  Guobao Wang; Jinyi Qi
Journal:  IEEE Trans Med Imaging       Date:  2012-08-08       Impact factor: 10.048

6.  Hepatic steatosis is associated with increased hepatic FDG uptake.

Authors:  Georgia Keramida; Jon Potts; Janice Bush; Sabina Dizdarevic; A Michael Peters
Journal:  Eur J Radiol       Date:  2014-02-07       Impact factor: 3.528

7.  Nonalcoholic fatty liver disease: intravoxel incoherent motion diffusion-weighted MR imaging-an experimental study in a rabbit model.

Authors:  Ijin Joo; Jeong Min Lee; Jeong Hee Yoon; Ja Jun Jang; Joon Koo Han; Byung Ihn Choi
Journal:  Radiology       Date:  2013-10-29       Impact factor: 11.105

8.  Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input.

Authors:  Sudheer D Rani; Samuel T Nemanich; Nicole Fettig; Kooresh I Shoghi
Journal:  Nucl Med Biol       Date:  2013-02-28       Impact factor: 2.408

9.  Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis.

Authors:  Minoru Kobayashi; Michihiro Suzuki; Hiroki Ikeda; Hideaki Takahashi; Nobuyuki Matsumoto; Shiro Maeyama; Shigeru Sase; Shiro Iino; Fumio Itoh
Journal:  Hepatol Res       Date:  2008-08-28       Impact factor: 4.288

10.  Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept.

Authors:  Gonca G Bural; Drew A Torigian; Anne Burke; Mohamed Houseni; Khaled Alkhawaldeh; Andrew Cucchiara; Sandip Basu; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2009-10-06       Impact factor: 3.488

View more
  9 in total

1.  Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling.

Authors:  Guobao Wang; Lorenzo Nardo; Mamta Parikh; Yasser G Abdelhafez; Elizabeth Li; Benjamin A Spencer; Jinyi Qi; Terry Jones; Simon R Cherry; Ramsey D Badawi
Journal:  J Nucl Med       Date:  2021-11-18       Impact factor: 11.082

2.  Structural and practical identifiability of dual-input kinetic modeling in dynamic PET of liver inflammation.

Authors:  Yang Zuo; Souvik Sarkar; Michael T Corwin; Kristin Olson; Ramsey D Badawi; Guobao Wang
Journal:  Phys Med Biol       Date:  2019-09-05       Impact factor: 3.609

Review 3.  Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation.

Authors:  Kenneth A Krohn; David R Vera
Journal:  Nucl Med Biol       Date:  2020-03-12       Impact factor: 2.408

Review 4.  Total-Body PET Kinetic Modeling and Potential Opportunities Using Deep Learning.

Authors:  Yiran Wang; Elizabeth Li; Simon R Cherry; Guobao Wang
Journal:  PET Clin       Date:  2021-08-03

5.  In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CT.

Authors:  Niklas Verloh; Ingo Einspieler; Kirsten Utpatel; Karin Menhart; Stefan Brunner; Frank Hofheinz; Jörg van den Hoff; Philipp Wiggermann; Matthias Evert; Christian Stroszczynski; Dirk Hellwig; Jirka Grosse
Journal:  EJNMMI Res       Date:  2018-11-09       Impact factor: 3.138

6.  Comparison of 18F-FDG, 18F-Fluoroacetate, and 18F-FEPPA for Imaging Liver Fibrosis in a Bile Duct-Ligated Rat Model.

Authors:  Chun-Yi Wu; Hsin-Hua Hsieh; Pei-An Chu; Wen-Hsiang Hong; Ting-Yu Chang; Chia-Fang Hsu; Siao-Ting Lin; Po-Hsun Su; Shin-Lei Peng
Journal:  Mol Imaging       Date:  2021-11-27       Impact factor: 4.488

7.  Dynamic chaotic gravitational search algorithm-based kinetic parameter estimation of hepatocellular carcinoma on 18F-FDG PET/CT.

Authors:  Jianfeng He; Tao Wang; Yongjin Li; Yinglei Deng; Shaobo Wang
Journal:  BMC Med Imaging       Date:  2022-02-06       Impact factor: 1.930

Review 8.  Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and Cancer.

Authors:  Miikka-Juhani Honka; Eleni Rebelos; Simona Malaspina; Pirjo Nuutila
Journal:  Metabolites       Date:  2022-04-02

9.  Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function.

Authors:  Jingnan Wang; Yunwen Shao; Bowei Liu; Xuezhu Wang; Barbara Katharina Geist; Xiang Li; Fang Li; Haitao Zhao; Marcus Hacker; Haiyan Ding; Hui Zhang; Li Huo
Journal:  BMC Med Imaging       Date:  2021-05-25       Impact factor: 1.930

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.